H.R. 4278 · 117th Congress

To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Stage
In committee
Sponsor
Gregory Murphy
Introduced
2021-06-30
Latest action
2021-07-01 · Referred to the Subcommittee on Health.

Action history

  1. 2021-07-01Referred to the Subcommittee on Health.
  2. 2021-06-30Introduced in House
  3. 2021-06-30Referred to the House Committee on Energy and Commerce.